Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

EBioMedicine. 2020 Feb:52:102628. doi: 10.1016/j.ebiom.2020.102628. Epub 2020 Jan 22.

Authors

Anna A Kiseleva¹, Erica A Golemis²

Affiliations

¹ Molecular Therapeutics Program, Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111, United States; Kazan Federal University, 420000 Kazan, Russian Federation.
² Molecular Therapeutics Program, Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111, United States. Electronic address: Erica.Golemis@fccc.edu.

No abstract available

Publication types

Comment

MeSH terms

Disease Progression
Drug Repositioning
Humans
Informatics
Polycystic Kidney, Autosomal Dominant*

Grants and funding